Potential value of vitamin E in cancer patients with venous access devices

Cynthia C Chernecky, Denise Macklin, Katherine Nugent, Jennifer L Waller

Research output: Contribution to journalArticle


Background: Vitamin E has antiplatelet, fibrinolytic and endotoxin properties that may help avoid the problems of occlusion or inability to withdraw blood from port VADs. Purpose: Disseminate information about the non-traditional therapeutic use of vitamin E associated with care of Venous Access Devices (VAD) in patients with cancer. Methodology: In-person focus groups. Sample of 22 cancer patients who had port Venous Access Devices (VAD). Findings: Fourteen percent (N = 3) of patients felt that taking vitamin E, 400 -800 IU per day orally, in capsule form, avoided the problems of occlusion or inability to withdraw blood from their current VAD. Practice Implications: The effects of vitamin E on occlusion and inability to withdraw blood in caring for patients who have port VADs, requires further investigation.

Original languageEnglish (US)
Pages (from-to)71-73
Number of pages3
JournalJAVA - Journal of the Association for Vascular Access
Issue number2
StatePublished - Jan 1 2008
Externally publishedYes


ASJC Scopus subject areas

  • Medicine (miscellaneous)

Cite this